Not everyone should immediately go on Fin if they are starting to bald
    Finasteride/Dutasteride 12/26/2023

    From the encyclopedia
    Finasteride β†’

    Frontline, gold standard treatment for combatting androgenic alopecia

    Dutasteride β†’

    Heavy duty finasteride that comes with higher risks

    At a glance
    In this question or advice post, the primary subjects mentioned are
    πŸ’Š Finasteride (oral)
    πŸ’Š Dutasteride (oral)
    the tone is 😐 neutral.

    Other terms

    The conversation suggests that people should consult a dermatologist to understand their type of hair loss before starting treatments like finasteride or dutasteride, especially if they have autoimmune issues or low DHT. Some participants believe in starting treatment like finasteride immediately if hair loss is due to DHT, while others recommend ruling out other causes and considering minoxidil first, especially for younger individuals.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Finasteride in Androgenetic Alopecia in Men

      research Finasteride in androgenetic alopecia in men

      June 2007 in “Advances in Dermatology and Allergology/PostΔ™py Dermatologii i Alergologii”
      This article discusses androgenetic alopecia in men and reports that finasteride at 1 mg/day for 24 months is generally well tolerated and may effectively inhibit hair loss.
      Systemic Treatment Options for Androgenic Alopecia

      research Systemic treatment options for androgenic alopecia

      March 2026 in “Lithuanian University of Health Sciences”
      In this study, a systematic review found that for androgenetic alopecia, systemic treatments like finasteride, dutasteride, and oral minoxidil are effective at slowing progression and promoting hair regrowth, with additional antiandrogen therapy options for women.
      Updates in Treatment for Androgenetic Alopecia

      research Updates in Treatment for Androgenetic Alopecia

      January 2025 in “Annals of Dermatology”
      This review discusses current and emerging treatments for androgenetic alopecia, covering mechanisms, efficacy, and safety of both androgen-targeted and non-androgen-targeted approaches, but reports no new clinical results.
      The Inflammatory Component of Androgenetic Alopecia

      research The inflammatory component of androgenetic alopecia

      3 citations , November 2021 in “Journal of The American Academy of Dermatology”
      This article discusses hormonal mechanisms underlying androgenetic alopecia but does not report any new findings; it reviews the roles of dihydrotestosterone and available FDA-approved treatments.